Wing Chow, PharmD, MPH

Director, HEOR Evidence Synthesis
Novo Nordisk Inc.

Poster(s):

• (33) Economic burden associated with systemic inflammation in patients with established atherosclerotic cardiovascular disease and stage 3-4 chronic kidney disease
  Wednesday, October 29, 2025